脑静脉窦血栓的血管内治疗:不同血管内手术的比较

S. A. Rangarajan, Dileep Ramachandran, Tanaya Mishra, Vikneshwaran Gunaseelan, Gopal K. Dash, Vivek J. Philip, Radhika Manohar, Kuldeep Shetty, Pavin Thomas, V. Huded
{"title":"脑静脉窦血栓的血管内治疗:不同血管内手术的比较","authors":"S. A. Rangarajan, Dileep Ramachandran, Tanaya Mishra, Vikneshwaran Gunaseelan, Gopal K. Dash, Vivek J. Philip, Radhika Manohar, Kuldeep Shetty, Pavin Thomas, V. Huded","doi":"10.4103/aian.aian_965_23","DOIUrl":null,"url":null,"abstract":"\n \n \n Cerebral venous sinus thrombosis (CVST) is a rare, treatable cause of stroke. Even though CVST has an established medical treatment, 15% of patients remain refractory to treatment. These patients may be candidates for endovascular treatment (EVT), yet the selection of patients remains a challenge. The study aims to understand the profile and outcome of patients treated with EVT and the type of procedure associated with good outcomes.\n \n \n \n This is a single-center, retrospective analysis of CVST patients who underwent EVT from 2009 till 2022. Patients who received only medical management were excluded. Modified Rankin Scale (mRS) ≤2 at 3 months was taken as the primary outcome. Secondary outcomes assessed were hospital stay, death, recurrence, mRS ≤ 2 at discharge, and angiographic recanalization.\n \n \n \n Fifty-two patients were included. Twenty-eight (53.8%) were males; the mean age was 33.3 ± 12.3 years. Headache (n = 44, 84.6%) predominated among the symptoms. The common risk factors were anemia (n = 13, 25.5%) and hyperhomocysteinemia (n = 13, 25.5%). Worsening of sensorium (n = 21, 40.3%) and non-improvement of symptoms (n = 15, 28.8%) were the common indications for the procedure. Twenty-five (48.1%) people underwent in situ thrombolysis (IST). Death occurred in eight (15.3%) patients. Thirty-six (73.5%; 36/49) patients had a good outcome at 3 months. IST had a significantly better outcome (mRS ≤ 2, n = 20, 80%) compared to other procedures (P = 0.04). Hospital stay was lesser in the IST subgroup, but without statistical significance. Midline shift >5 mm (odds ratio [OR] 6.8 [1.5–30.9], P = 0.01) and Glasgow Coma Scale <9 before the procedure (OR 27.2 [3.1–236.4], P = 0.002) predicted bad outcomes at 3 months. Female gender (OR 4.5 [1.07–8.8], P = 0.03), presence of altered sensorium (OR 10.2 [1.2–87.5], P = 0.01), encephalopathic syndrome (P = 0.02), presence of parenchymal bleed (OR 3.7 [0.9–4.5], P = 0.04), and midline shift (OR 4.8 [1.1–20.2], P = 0.03) were associated with poor outcome at discharge.\n \n \n \n EVT yielded good outcomes in carefully selected, medically refractory patients of CVST. IST performed well compared to other procedures.\n","PeriodicalId":504920,"journal":{"name":"Annals of Indian Academy of Neurology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Endovascular Treatment for Cerebral Venous Sinus Thrombosis: Comparison among Different Endovascular Procedures\",\"authors\":\"S. A. Rangarajan, Dileep Ramachandran, Tanaya Mishra, Vikneshwaran Gunaseelan, Gopal K. Dash, Vivek J. Philip, Radhika Manohar, Kuldeep Shetty, Pavin Thomas, V. Huded\",\"doi\":\"10.4103/aian.aian_965_23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n \\n \\n Cerebral venous sinus thrombosis (CVST) is a rare, treatable cause of stroke. Even though CVST has an established medical treatment, 15% of patients remain refractory to treatment. These patients may be candidates for endovascular treatment (EVT), yet the selection of patients remains a challenge. The study aims to understand the profile and outcome of patients treated with EVT and the type of procedure associated with good outcomes.\\n \\n \\n \\n This is a single-center, retrospective analysis of CVST patients who underwent EVT from 2009 till 2022. Patients who received only medical management were excluded. Modified Rankin Scale (mRS) ≤2 at 3 months was taken as the primary outcome. Secondary outcomes assessed were hospital stay, death, recurrence, mRS ≤ 2 at discharge, and angiographic recanalization.\\n \\n \\n \\n Fifty-two patients were included. Twenty-eight (53.8%) were males; the mean age was 33.3 ± 12.3 years. Headache (n = 44, 84.6%) predominated among the symptoms. The common risk factors were anemia (n = 13, 25.5%) and hyperhomocysteinemia (n = 13, 25.5%). Worsening of sensorium (n = 21, 40.3%) and non-improvement of symptoms (n = 15, 28.8%) were the common indications for the procedure. Twenty-five (48.1%) people underwent in situ thrombolysis (IST). Death occurred in eight (15.3%) patients. Thirty-six (73.5%; 36/49) patients had a good outcome at 3 months. IST had a significantly better outcome (mRS ≤ 2, n = 20, 80%) compared to other procedures (P = 0.04). Hospital stay was lesser in the IST subgroup, but without statistical significance. Midline shift >5 mm (odds ratio [OR] 6.8 [1.5–30.9], P = 0.01) and Glasgow Coma Scale <9 before the procedure (OR 27.2 [3.1–236.4], P = 0.002) predicted bad outcomes at 3 months. Female gender (OR 4.5 [1.07–8.8], P = 0.03), presence of altered sensorium (OR 10.2 [1.2–87.5], P = 0.01), encephalopathic syndrome (P = 0.02), presence of parenchymal bleed (OR 3.7 [0.9–4.5], P = 0.04), and midline shift (OR 4.8 [1.1–20.2], P = 0.03) were associated with poor outcome at discharge.\\n \\n \\n \\n EVT yielded good outcomes in carefully selected, medically refractory patients of CVST. IST performed well compared to other procedures.\\n\",\"PeriodicalId\":504920,\"journal\":{\"name\":\"Annals of Indian Academy of Neurology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Indian Academy of Neurology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/aian.aian_965_23\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Indian Academy of Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/aian.aian_965_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

脑静脉窦血栓形成(CVST)是一种罕见的、可治疗的脑卒中病因。尽管 CVST 已有成熟的药物治疗方法,但仍有 15% 的患者难治。这些患者可能适合接受血管内治疗(EVT),但患者的选择仍是一个难题。本研究旨在了解接受 EVT 治疗的患者的概况和疗效,以及与良好疗效相关的手术类型。 这是一项对 2009 年至 2022 年期间接受 EVT 治疗的 CVST 患者进行的单中心回顾性分析。仅接受药物治疗的患者不包括在内。3个月时改良朗肯量表(mRS)≤2为主要评估结果。次要评估结果包括住院时间、死亡、复发、出院时 mRS ≤ 2 以及血管造影再通。 共纳入 52 名患者。男性28人(53.8%),平均年龄(33.3 ± 12.3)岁。症状以头痛为主(44 人,占 84.6%)。常见的风险因素是贫血(13 人,占 25.5%)和高同型半胱氨酸血症(13 人,占 25.5%)。感觉恶化(21 人,40.3%)和症状无改善(15 人,28.8%)是手术的常见适应症。25人(48.1%)接受了原位溶栓治疗(IST)。8名患者(15.3%)死亡。36名(73.5%;36/49)患者在3个月后疗效良好。与其他手术相比,IST的疗效明显更好(mRS ≤ 2,n = 20,80%)(P = 0.04)。IST 亚组的住院时间较短,但无统计学意义。中线移位 >5 mm(几率比 [OR] 6.8 [1.5-30.9],P = 0.01)和术前格拉斯哥昏迷量表 <9(OR 27.2 [3.1-236.4],P = 0.002)预示着 3 个月后的不良后果。女性性别(OR 4.5 [1.07-8.8],P = 0.03)、感觉改变(OR 10.2 [1.2-87.5],P = 0.01)、脑病综合征(P = 0.02)、实质出血(OR 3.7 [0.9-4.5],P = 0.04)和中线移位(OR 4.8 [1.1-20.2],P = 0.03)与出院时的不良预后有关。 对于经过精心挑选、药物难治的 CVST 患者,EVT 取得了良好的疗效。与其他手术相比,IST效果良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Endovascular Treatment for Cerebral Venous Sinus Thrombosis: Comparison among Different Endovascular Procedures
Cerebral venous sinus thrombosis (CVST) is a rare, treatable cause of stroke. Even though CVST has an established medical treatment, 15% of patients remain refractory to treatment. These patients may be candidates for endovascular treatment (EVT), yet the selection of patients remains a challenge. The study aims to understand the profile and outcome of patients treated with EVT and the type of procedure associated with good outcomes. This is a single-center, retrospective analysis of CVST patients who underwent EVT from 2009 till 2022. Patients who received only medical management were excluded. Modified Rankin Scale (mRS) ≤2 at 3 months was taken as the primary outcome. Secondary outcomes assessed were hospital stay, death, recurrence, mRS ≤ 2 at discharge, and angiographic recanalization. Fifty-two patients were included. Twenty-eight (53.8%) were males; the mean age was 33.3 ± 12.3 years. Headache (n = 44, 84.6%) predominated among the symptoms. The common risk factors were anemia (n = 13, 25.5%) and hyperhomocysteinemia (n = 13, 25.5%). Worsening of sensorium (n = 21, 40.3%) and non-improvement of symptoms (n = 15, 28.8%) were the common indications for the procedure. Twenty-five (48.1%) people underwent in situ thrombolysis (IST). Death occurred in eight (15.3%) patients. Thirty-six (73.5%; 36/49) patients had a good outcome at 3 months. IST had a significantly better outcome (mRS ≤ 2, n = 20, 80%) compared to other procedures (P = 0.04). Hospital stay was lesser in the IST subgroup, but without statistical significance. Midline shift >5 mm (odds ratio [OR] 6.8 [1.5–30.9], P = 0.01) and Glasgow Coma Scale <9 before the procedure (OR 27.2 [3.1–236.4], P = 0.002) predicted bad outcomes at 3 months. Female gender (OR 4.5 [1.07–8.8], P = 0.03), presence of altered sensorium (OR 10.2 [1.2–87.5], P = 0.01), encephalopathic syndrome (P = 0.02), presence of parenchymal bleed (OR 3.7 [0.9–4.5], P = 0.04), and midline shift (OR 4.8 [1.1–20.2], P = 0.03) were associated with poor outcome at discharge. EVT yielded good outcomes in carefully selected, medically refractory patients of CVST. IST performed well compared to other procedures.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信